Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117019432 | 11701943 | 2 | F | 20160811 | 20151105 | 20160819 | EXP | US-ARIAD-2015US005381 | ARIAD | 0.00 | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117019432 | 11701943 | 1 | PS | ICLUSIG | PONATINIB | 1 | Oral | 30 MG, QD | U | U | 31L14H01 | 203469 | 30 | MG | TABLET | ||||
| 117019432 | 11701943 | 2 | SS | ICLUSIG | PONATINIB | 1 | Oral | 30 MG, QD | U | U | 31L14H01 | 203469 | 30 | MG | TABLET | ||||
| 117019432 | 11701943 | 3 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117019432 | 11701943 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117019432 | 11701943 | OT |
| 117019432 | 11701943 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117019432 | 11701943 | Death | |
| 117019432 | 11701943 | Headache | |
| 117019432 | 11701943 | Paraesthesia | |
| 117019432 | 11701943 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117019432 | 11701943 | 1 | 20150804 | 0 |